Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1964 1
1965 1
1966 1
1968 6
1969 14
1970 15
1971 15
1972 20
1973 18
1974 15
1975 24
1976 36
1977 28
1978 24
1979 26
1980 14
1981 13
1982 22
1983 22
1984 11
1985 14
1986 14
1987 23
1988 22
1989 27
1990 16
1991 30
1992 29
1993 28
1994 24
1995 16
1996 37
1997 20
1998 30
1999 19
2000 31
2001 27
2002 26
2003 22
2004 34
2005 19
2006 23
2007 97
2008 25
2009 20
2010 20
2011 31
2012 17
2013 21
2014 20
2015 26
2016 35
2017 23
2018 25
2019 22
2020 23
2021 29
2022 37
2023 44
2024 17

Text availability

Article attribute

Article type

Publication date

Search Results

1,321 results

Results by year

Filters applied: . Clear all
The following term was not found in PubMed: Abasali
Page 1
Defibrinogenating enzymes.
Bell WR Jr. Bell WR Jr. Drugs. 1997;54 Suppl 3:18-30; discussion 30-1. doi: 10.2165/00003495-199700543-00005. Drugs. 1997. PMID: 9360849 Review.
Ancrod cleaves only the A-fibrinopeptides, but not the B-fibrinopeptides, from fibrinogen; this contrasts with thrombin, batroxobin and crotalase, which cleave both fibrinopeptides A and B. ...In the coagulation laboratory, ancrod, batroxobin and crotalase may be us …
Ancrod cleaves only the A-fibrinopeptides, but not the B-fibrinopeptides, from fibrinogen; this contrasts with thrombin, batroxobin a …
Experimental ancrod (Arvin) for acute ischemic stroke: nursing implications.
Jahnke H. Jahnke H. J Neurosci Nurs. 1991 Dec;23(6):386-9. doi: 10.1097/01376517-199112000-00008. J Neurosci Nurs. 1991. PMID: 1839548 Review.
Aggressive, early intervention is the key to overall neurological improvement of stroke patients. Ancrod, a purified protein fraction of venom from the Malayan pit viper, has been shown to produce rapid and effective defibrinogenation in humans. A current clinical trial wi …
Aggressive, early intervention is the key to overall neurological improvement of stroke patients. Ancrod, a purified protein fraction …
Chickenpox (varicella).
Arvin AM. Arvin AM. Contrib Microbiol. 1999;3:96-110. doi: 10.1159/000060317. Contrib Microbiol. 1999. PMID: 10599524 Review. No abstract available.
Heparin-induced thrombocytopenia.
Gupta AK, Kovacs MJ, Sauder DN. Gupta AK, et al. Ann Pharmacother. 1998 Jan;32(1):55-9. doi: 10.1345/aph.16388. Ann Pharmacother. 1998. PMID: 9475822 Free article.
Enzymes as therapeutic agents.
Cooney DA, Rosenbluth RJ. Cooney DA, et al. Adv Pharmacol Chemother. 1975;12(0):185-289. doi: 10.1016/s1054-3589(08)60222-7. Adv Pharmacol Chemother. 1975. PMID: 168755 Review. No abstract available.
Magnetic resonance imaging and outcome.
Fehlings MG, Arvin B. Fehlings MG, et al. J Neurosurg Spine. 2010 Jan;12(1):56-8. doi: 10.3171/2009.6.SPINE09467. J Neurosurg Spine. 2010. PMID: 20043765 No abstract available.
Arvin William Mann 1908-1971.
[No authors listed] [No authors listed] J Periodontol. 1972 Mar;43(3):145. doi: 10.1902/jop.1972.43.3.145. J Periodontol. 1972. PMID: 4552488 No abstract available.
Prevention of venous thromboembolism.
Gallus AS, Hirsh J. Gallus AS, et al. Semin Thromb Hemost. 1976 Apr;2(4):232-90. doi: 10.1055/s-0028-1086126. Semin Thromb Hemost. 1976. PMID: 798276 Review.
Antithrombotic drugs: part II.
Gallus AS, Hirsh J. Gallus AS, et al. Drugs. 1976;12(2):132-57. doi: 10.2165/00003495-197612020-00002. Drugs. 1976. PMID: 786606 Review.
The defibrinating agent ancrod has had limited clinical trial, but appears to give no advantages over heparin. ...
The defibrinating agent ancrod has had limited clinical trial, but appears to give no advantages over heparin. ...
Varicella vaccine--the first six years.
Arvin AM. Arvin AM. N Engl J Med. 2001 Mar 29;344(13):1007-9. doi: 10.1056/NEJM200103293441310. N Engl J Med. 2001. PMID: 11274629 No abstract available.
1,321 results